MedPath

The effect of Tamsulosin and Solifenacin in the treatment of double J stent-related urinary symptoms

Phase 3
Conditions
lower urinary tract symptoms, ureteral stone.
Urinary calculus, unspecified
N20.9
Registration Number
IRCT20200831048564N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

patients with ureteral stones undergoing unilateral transurethral lithotripsy

Exclusion Criteria

History of surgery on the urinary system
Performing urethroscopy or double j implantation bilaterally
History of LUTS symptoms following BPH
Other diseases of the urinary system such as neurogenic bladder and overactive bladder
Concomitant use of anti-adrenergic and anticholinergic drugs
pregnancy
Drug Allergy
Occurrence of major complications following surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reteral stent urinary symptoms. Timepoint: 2 weeks after intervention. Method of measurement: Based on Ureteral Stent Symptoms Questionnaire (USSQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath